{"id":"https://openalex.org/W2117624154","doi":"https://doi.org/10.1046/j.1365-2133.2003.05239.x","title":"Alefacept therapy produces remission for patients with chronic plaque psoriasis","display_name":"Alefacept therapy produces remission for patients with chronic plaque psoriasis","publication_year":2003,"publication_date":"2003-04-01","ids":{"openalex":"https://openalex.org/W2117624154","doi":"https://doi.org/10.1046/j.1365-2133.2003.05239.x","mag":"2117624154","pmid":"https://pubmed.ncbi.nlm.nih.gov/12752139"},"language":"en","primary_location":{"id":"doi:10.1046/j.1365-2133.2003.05239.x","doi":"https://doi.org/10.1046/j.1365-2133.2003.05239.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2133.2003.05239.x","pdf_url":null,"source":{"id":"https://openalex.org/S45720283","display_name":"British Journal of Dermatology","issn_l":"0007-0963","issn":["0007-0963","1365-2133"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Dermatology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://hdl.handle.net/2027.42/75170","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111575047","display_name":"Gerald G. Krueger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I4210148268","display_name":"University of Utah Health Care","ror":"https://ror.org/047s7ex42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G.G. Krueger","raw_affiliation_strings":["Department of Dermatology, University of Utah Health Sciences Center, 50 North Medical Drive, Suite 4B 454, Salt Lake City, UT 84132, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, University of Utah Health Sciences Center, 50 North Medical Drive, Suite 4B 454, Salt Lake City, UT 84132, USA","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I4210148268"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007703201","display_name":"Charles N. Ellis","orcid":"https://orcid.org/0000-0001-9436-7628","observed_orcids":["https://orcid.org/0000-0001-9436-7628"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]},{"id":"https://openalex.org/I4210111446","display_name":"A. Alfred Taubman Health Care Center","ror":"https://ror.org/01rh00978","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210111446","https://openalex.org/I4210114445"]},{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"C.N. Ellis","raw_affiliation_strings":["Department of Dermatology, University of Michigan Medical School, 1910 Taubman Center 0314, Ann Arbor, MI 48109\u20100314, U.S.A","University of Utah,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, University of Michigan Medical School, 1910 Taubman Center 0314, Ann Arbor, MI 48109\u20100314, U.S.A","institution_ids":["https://openalex.org/I27837315","https://openalex.org/I4210111446","https://openalex.org/I4210114445"]},{"raw_affiliation_string":"University of Utah,","institution_ids":["https://openalex.org/I223532165"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5007703201"],"corresponding_institution_ids":["https://openalex.org/I223532165","https://openalex.org/I27837315","https://openalex.org/I4210111446","https://openalex.org/I4210114445"],"apc_list":{"value":3731,"currency":"GBP","value_usd":4920},"apc_paid":null,"fwci":3.542,"has_fulltext":true,"cited_by_count":75,"citation_normalized_percentile":{"value":0.93761851,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"148","issue":"4","first_page":"784","last_page":"788"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alefacept","display_name":"alefacept","score":1.0},{"id":"https://openalex.org/keywords/plaque-psoriasis","display_name":"plaque psoriasis","score":0.984000027179718},{"id":"https://openalex.org/keywords/remission","display_name":"remission","score":0.8230000138282776},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.7450000047683716},{"id":"https://openalex.org/keywords/memory-effector-t-cells","display_name":"memory/effector T cells","score":0.8220000267028809},{"id":"https://openalex.org/keywords/disease-free-interval","display_name":"disease-free interval","score":0.8500000238418579},{"id":"https://openalex.org/keywords/physician-s-global-assessment","display_name":"physician global assessment","score":0.6510000228881836}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9097903966903687},{"id":"https://openalex.org/C3020604521","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Plaque psoriasis","level":3,"score":0.815091073513031},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.7920182943344116},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5581331849098206},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5137065649032593},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.49542057514190674},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.47167620062828064},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43927210569381714},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.33951061964035034},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.146517813205719},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077944","descriptor_name":"Alefacept","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019233","descriptor_name":"Retreatment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1046/j.1365-2133.2003.05239.x","doi":"https://doi.org/10.1046/j.1365-2133.2003.05239.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2133.2003.05239.x","pdf_url":null,"source":{"id":"https://openalex.org/S45720283","display_name":"British Journal of Dermatology","issn_l":"0007-0963","issn":["0007-0963","1365-2133"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Dermatology","raw_type":"journal-article"},{"id":"pmid:12752139","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12752139","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The British journal of dermatology","raw_type":"Clinical Trial"},{"id":"pmh:oai:deepblue.lib.umich.edu:2027.42/75170","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/2027.42/75170","pdf_url":"https://hdl.handle.net/2027.42/75170","source":{"id":"https://openalex.org/S4306400393","display_name":"Deep Blue (University of Michigan)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I27837315","host_organization_name":"University of Michigan","host_organization_lineage":["https://openalex.org/I27837315"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":{"id":"pmh:oai:deepblue.lib.umich.edu:2027.42/75170","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/2027.42/75170","pdf_url":"https://hdl.handle.net/2027.42/75170","source":{"id":"https://openalex.org/S4306400393","display_name":"Deep Blue (University of Michigan)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I27837315","host_organization_name":"University of Michigan","host_organization_lineage":["https://openalex.org/I27837315"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320308604","display_name":"Biogen","ror":"https://ror.org/02jqkb192"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2117624154.pdf","grobid_xml":"https://content.openalex.org/works/W2117624154.grobid-xml"},"referenced_works_count":23,"referenced_works":["https://openalex.org/W1568059997","https://openalex.org/W1947836173","https://openalex.org/W1964227521","https://openalex.org/W1969580598","https://openalex.org/W2012009723","https://openalex.org/W2012980289","https://openalex.org/W2019222650","https://openalex.org/W2019276276","https://openalex.org/W2019947683","https://openalex.org/W2022419183","https://openalex.org/W2041635511","https://openalex.org/W2045813582","https://openalex.org/W2079194231","https://openalex.org/W2083778751","https://openalex.org/W2084322320","https://openalex.org/W2118894233","https://openalex.org/W2142489504","https://openalex.org/W2142653395","https://openalex.org/W2150537204","https://openalex.org/W2154152572","https://openalex.org/W2163456436","https://openalex.org/W2396590096","https://openalex.org/W2403921929"],"related_works":["https://openalex.org/W2049093271","https://openalex.org/W1771617713","https://openalex.org/W2032132548","https://openalex.org/W4235081398","https://openalex.org/W2284439647","https://openalex.org/W4247187408","https://openalex.org/W4232540238","https://openalex.org/W4250512170","https://openalex.org/W2162894611","https://openalex.org/W2071394943"],"abstract_inverted_index":{"BACKGROUND:":[0],"Alefacept,":[1],"human":[2],"LFA-3/IgG1":[3],"fusion":[4],"protein,":[5],"is":[6,42,157],"a":[7,39,45,54,116,135,158],"novel":[8],"biological":[9,159],"agent":[10,160],"currently":[11],"being":[12],"developed":[13],"for":[14,134,141,161],"the":[15,24,33,36,82,89,121,124,162],"treatment":[16,163],"of":[17,35,62,112,123,137,153,164],"chronic":[18,69,165],"plaque":[19,70,166],"psoriasis.":[20],"Alefacept":[21,156],"selectively":[22],"reduces":[23],"memory-effector":[25],"T":[26],"cells":[27],"that":[28,47,168],"have":[29],"been":[30],"implicated":[31],"in":[32,65,81,104],"pathogenesis":[34],"disease;":[37],"as":[38,44,78,80],"result,":[40],"alefacept":[41,64,93],"classified":[43],"therapy":[46],"induces":[48],"remission":[49,90],"(so-called":[50],"'remittive'":[51],"therapy).":[52],"In":[53,128],"previously":[55],"published":[56],"randomized,":[57],"placebo-controlled":[58],"phase":[59],"II":[60],"study":[61],"intravenous":[63],"229":[66],"patients":[67,105],"with":[68],"psoriasis,":[71],"clinical":[72],"improvement":[73],"was":[74,100,102],"observed":[75],"during":[76],"dosing":[77],"well":[79],"postdosing":[83],"follow-up":[84,125],"period.":[85],"OBJECTIVES:":[86],"To":[87],"assess":[88],"period":[91],"following":[92],"therapy.":[94,176],"METHODS:":[95],"The":[96],"time":[97,173],"before":[98],"re-treatment":[99],"required":[101],"measured":[103],"who":[106],"were":[107,132],"'clear'":[108],"or":[109],"'almost":[110],"clear'":[111],"disease":[113,149],"according":[114],"to":[115,143],"physician":[117],"global":[118],"assessment":[119],"at":[120],"end":[122],"phase.":[126],"RESULTS:":[127],"these":[129],"patients,":[130],"responses":[131],"sustained":[133],"median":[136],"10":[138],"months,":[139],"and":[140,172],"up":[142],"18":[144],"months.":[145],"No":[146],"patient":[147],"reported":[148],"rebound":[150],"after":[151],"cessation":[152],"alefacept.":[154],"CONCLUSIONS:":[155],"psoriasis":[167],"provides":[169],"disease-free":[170],"intervals":[171],"off":[174],"drug":[175]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}